Sahajanand Medical Technologies IPO entered its third and final day of bidding on Monday. The issue was commanding a grey market premium (GMP) of 7%, indicating expectations of potential listing gains in the unofficial market. However, the GMP is subject to fluctuations and does not guarantee the stock’s actual listing price or listing gains.
On Day 2, the IPO was subscribed 82% overall against 97.50 lakh shares on offer. The Retail Individual Investors (RIIs) category saw 83% subscription against 47.50 lakh shares reserved for retail investors.